March 4, 2013 – Three Pillars Biotechnology Consulting is proud to be a sponsor of the Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries) and work with Ann Nordgren, of the Clinical Genetics Department at the Karolinska University Hospital. Three Pillars Biotechnology Consulting will provide expert support for Ann Nordgren’s research on Osteoporosis and osteogenesis imperfecta.  The Karolinksa University Hospital team was selected out of 77 applicants covering 67 types of rare disease.

Osteogenesis imperfect is a skeletal disorder characterized by compromised bone strength and increased risk of fractures. “Three Pillars is excited to contribute to the advancement of osteogenesis imperfect research.  We will provide practical solutions for genetic analysis, and disease model development, so that someday better diagnosis and treatment are available.” –Erik Foehr, Ph.D.

Three Pillars Biotechnology Consulting joins 19 other companies as service donors for the competition, hosted by Assay Depot and Rare Genomics Institute. Rare Genomic Institute’s expert panel selected winners for the service donation. The total value of all services reached $500,000, which will go towards helping accelerate rare disease research. To view all service winners and company donations, please visit challenge.assaydepot.com/rare-disease-awards and:

 http://www.prnewswire.com/news-releases/assay-depot-and-rare-genomics-institute-award-prizes-to-study-26-rare-diseases-193848181.html.

The competition also features a $10,000 prize with the winner being chosen by Facebook voting. The community can participate by voting for their favorite research proposals on Facebook at http://www.facebook.com/raregenomics.


Three Pillars Biotechnology Consulting www.threepillarsbiotech.com

Three Pillars Biotechnology Consulting provides expert advice, guidance and practical solutions for your drug development project.  Erik Foehr, Ph.D., has over 15 years academic and industry experience.  He is an expert in the areas of regulated bioanalysis, analytical studies, diagnostics, and drug development.